{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:17:54Z","timestamp":1785471474659,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81721091"],"award-info":[{"award-number":["81721091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver ischemia\/reperfusion (I\/R) injury is a major clinical concern of liver transplantation, which accounts for organ rejection and liver dysfunction. The adaptor protein p66Shc acts as a crucial redox enzyme and is implicated in liver I\/R. Elevated p66Shc expression is associated with hepatocellular apoptosis in liver I\/R, but the molecular mechanisms of p66Shc responsible for its aberrant expression and function remain unknown. In the present study, hepatocyte-specific p66Shc-knockdown mice exhibited clear inhibition in hepatocellular apoptosis and oxidative stress under liver I\/R, while hepatocyte-specific p66Shc overexpression mice displayed the deteriorative impairment. Mechanistically, p66Shc-triggered mitochondrial fission and apoptosis in liver I\/R by mediating ROS-driven Drp1 activation. Furthermore, a screening for p66Shc-interacting proteins identified ubiquitin-specific protease 15 (USP15) as a mediator critical for abnormal p66Shc expression. Specifically, USP15 interacted with the SH2 domain of p66Shc and maintained its stabilization by removing ubiquitin. In vivo, p66Shc knockdown abrogated USP15-driven hepatocellular apoptosis, whereas p66Shc overexpression counteracted the antiapoptotic effect of USP15 silencing in response to liver I\/R. There was clinical evidence for the positive association between p66Shc and USP15 in patients undergoing liver transplantation. In summary, p66Shc contributes to mitochondrial fission and apoptosis associated with Drp1 activation, and abnormal p66Shc expression relies on the activity of USP15 deubiquitination under liver I\/R. The current study sheds new light on the molecular mechanism of p66Shc, and identifies USP15 as a novel mediator of p66Shc to facilitate better therapeutics against liver I\/R.<\/jats:p>","DOI":"10.1038\/s41419-022-05277-8","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T12:03:01Z","timestamp":1664193781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["USP15 regulates p66Shc stability associated with Drp1 activation in liver ischemia\/reperfusion"],"prefix":"10.1038","volume":"13","author":[{"given":"Xinyao","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianrang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-8261","authenticated-orcid":false,"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"5277_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/hep.30508","volume":"70","author":"EB Thorgersen","year":"2019","unstructured":"Thorgersen EB, Barratt-Due A, Haugaa H, Harboe M, Pischke SE, Nilsson PH, et al. The role of complement in liver injury, regeneration, and transplantation. Hepatology. 2019;70:725\u201336.","journal-title":"Hepatology."},{"key":"5277_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jhep.2013.06.017","volume":"59","author":"C Peralta","year":"2013","unstructured":"Peralta C, Jim\u00e9nez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59:1094\u2013106.","journal-title":"J Hepatol"},{"key":"5277_CR3","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1111\/bph.13478","volume":"174","author":"F Di Lisa","year":"2017","unstructured":"Di Lisa F, Giorgio M, Ferdinandy P, Schulz R. New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases. Br J Pharmacol. 2017;174:1690\u2013703.","journal-title":"Br J Pharmacol"},{"key":"5277_CR4","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/mnfr.201500878","volume":"60","author":"L Gao","year":"2016","unstructured":"Gao L, Shan W, Zeng W, Hu Y, Wang G, Tian X, et al. Carnosic acid alleviates chronic alcoholic liver injury by regulating the SIRT1\/ChREBP and SIRT1\/p66shc pathways in rats. Mol Nutr Food Res. 2016;60:1902\u201311.","journal-title":"Mol Nutr Food Res"},{"key":"5277_CR5","doi-asserted-by":"publisher","first-page":"e1833","DOI":"10.1038\/cddis.2015.196","volume":"6","author":"W Shan","year":"2015","unstructured":"Shan W, Gao L, Zeng W, Hu Y, Wang G, Li M, et al. Activation of the SIRT1\/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. Cell Death Dis. 2015;6:e1833.","journal-title":"Cell Death Dis"},{"key":"5277_CR6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41419-020-03160-y","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhao Y, Sun R, Sun Y, Liu D, Lin M, et al. circ-CBFB upregulates p66Shc to perturb mitochondrial dynamics in APAP-induced liver injury. Cell Death Dis. 2020;11:953.","journal-title":"Cell Death Dis"},{"key":"5277_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.7150\/thno.29620","volume":"9","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Wang Z, Feng D, Zhao H, Lin M, Hu Y, et al. p66Shc contributes to liver fibrosis through the regulation of mitochondrial reactive oxygen species. Theranostics. 2019;9:1510\u201322.","journal-title":"Theranostics."},{"key":"5277_CR8","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1097\/CCM.0000000000000246","volume":"42","author":"H Yan","year":"2014","unstructured":"Yan H, Jihong Y, Feng Z, Xiaomei X, Xiaohan Z, Guangzhi W, et al. Sirtuin 1-mediated inhibition of p66shc expression alleviates liver ischemia\/reperfusion injury. Crit Care Med. 2014;42:e373\u201381.","journal-title":"Crit Care Med"},{"key":"5277_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1042\/CS20180005","volume":"132","author":"M Zhan","year":"2018","unstructured":"Zhan M, Usman I, Yu J, Ruan L, Bian X, Yang J, et al. Perturbations in mitochondrial dynamics by p66Shc lead to renal tubular oxidative injury in human diabetic nephropathy. Clin Sci (Lond, Engl: 1979). 2018;132:1297\u2013314.","journal-title":"Clin Sci (Lond, Engl: 1979)"},{"key":"5277_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","volume":"15","author":"DC Chan","year":"2020","unstructured":"Chan DC. Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol. 2020;15:235\u201359.","journal-title":"Annu Rev Pathol"},{"key":"5277_CR11","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1242\/jcs.199562","volume":"130","author":"F Kraus","year":"2017","unstructured":"Kraus F, Ryan MT. The constriction and scission machineries involved in mitochondrial fission. J Cell Sci. 2017;130:2953\u201360.","journal-title":"J Cell Sci"},{"key":"5277_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.redox.2014.11.006","volume":"4","author":"HM Ni","year":"2015","unstructured":"Ni HM, Williams JA, Ding WX. Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 2015;4:6\u201313.","journal-title":"Redox Biol"},{"key":"5277_CR13","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/hep.29326","volume":"66","author":"C Zhang","year":"2017","unstructured":"Zhang C, Huang J, An W. Hepatic stimulator substance resists hepatic ischemia\/reperfusion injury by regulating Drp1 translocation and activation. Hepatology. 2017;66:1989\u20132001.","journal-title":"Hepatology."},{"key":"5277_CR14","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41418-020-00641-7","volume":"28","author":"J Huang","year":"2021","unstructured":"Huang J, Xie P, Dong Y, An W. Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury. Cell Death Differ. 2021;28:1174\u201392.","journal-title":"Cell Death Differ"},{"key":"5277_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/CIRCRESAHA.117.311307","volume":"122","author":"K Tsushima","year":"2018","unstructured":"Tsushima K, Bugger H, Wende AR, Soto J, Jenson GA, Tor AR, et al. Mitochondrial reactive oxygen species in lipotoxic hearts induce post-translational modifications of AKAP121, DRP1, and OPA1 that promote mitochondrial fission. Circulation Res. 2018;122:58\u201373.","journal-title":"Circulation Res"},{"key":"5277_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","volume":"122","author":"M Giorgio","year":"2005","unstructured":"Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 2005;122:221\u201333.","journal-title":"Cell."},{"key":"5277_CR17","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1126\/science.1069004","volume":"295","author":"S Nemoto","year":"2002","unstructured":"Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science. 2002;295:2450\u20132.","journal-title":"Science."},{"key":"5277_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1126\/science.1135380","volume":"315","author":"P Pinton","year":"2007","unstructured":"Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science. 2007;315:659\u201363.","journal-title":"Science."},{"key":"5277_CR19","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1038\/sj.onc.1205513","volume":"21","author":"M Trinei","year":"2002","unstructured":"Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E, et al. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene. 2002;21:3872\u20138.","journal-title":"Oncogene."},{"key":"5277_CR20","doi-asserted-by":"publisher","first-page":"101139","DOI":"10.1016\/j.arr.2020.101139","volume":"63","author":"HA Mir","year":"2020","unstructured":"Mir HA, Ali R, Mushtaq U, Khanday FA. Structure-functional implications of longevity protein p66Shc in health and disease. Ageing Res Rev. 2020;63:101139.","journal-title":"Ageing Res Rev"},{"key":"5277_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/CIRCRESAHA.111.243592","volume":"109","author":"S Zhou","year":"2011","unstructured":"Zhou S, Chen HZ, Wan YZ, Zhang QJ, Wei YS, Huang S, et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circulation Res. 2011;109:639\u201348.","journal-title":"Circulation Res"},{"key":"5277_CR22","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1073\/pnas.1614112114","volume":"114","author":"S Kumar","year":"2017","unstructured":"Kumar S, Kim YR, Vikram A, Naqvi A, Li Q, Kassan M, et al. Sirtuin1-regulated lysine acetylation of p66Shc governs diabetes-induced vascular oxidative stress and endothelial dysfunction. Proc Natl Acad Sci USA. 2017;114:1714\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5277_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cell.2010.11.012","volume":"143","author":"MJ Clague","year":"2010","unstructured":"Clague MJ, Urb\u00e9 S. Ubiquitin: same molecule, different degradation pathways. Cell. 2010;143:682\u20135.","journal-title":"Cell."},{"key":"5277_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/ijms18030483","volume":"18","author":"CK Chou","year":"2017","unstructured":"Chou CK, Chang YT, Korinek M, Chen YT, Yang YT, Leu S, et al. The regulations of deubiquitinase USP15 and Its pathophysiological mechanisms in diseases. Int J Mol Sci. 2017;18:483.","journal-title":"Int J Mol Sci"},{"key":"5277_CR25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/ni.2885","volume":"15","author":"Q Zou","year":"2014","unstructured":"Zou Q, Jin J, Hu H, Li HS, Romano S, Xiao Y, et al. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat Immunol. 2014;15:562\u201370.","journal-title":"Nat Immunol"},{"key":"5277_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09232-8","volume":"10","author":"Y Peng","year":"2019","unstructured":"Peng Y, Liao Q, Tan W, Peng C, Hu Z, Chen Y, et al. The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors. Nat Commun. 2019;10:1224.","journal-title":"Nat Commun"},{"key":"5277_CR27","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/hep.30978","volume":"71","author":"Q Sun","year":"2020","unstructured":"Sun Q, Zhang Z, Lu Y, Liu Q, Xu X, Xu J, et al. Loss of xanthine oxidoreductase potentiates propagation of hepatocellular carcinoma stem cells. Hepatology. 2020;71:2033\u201349.","journal-title":"Hepatology."},{"key":"5277_CR28","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.31147","volume":"72","author":"Z Yi","year":"2020","unstructured":"Yi Z, Deng M, Scott MJ, Fu G, Loughran PA, Lei Z, et al. Immune-responsive gene 1\/itaconate activates nuclear factor erythroid 2-related factor 2 in hepatocytes to protect against liver ischemia-reperfusion injury. Hepatology. 2020;72:1394\u2013411.","journal-title":"Hepatology."},{"key":"5277_CR29","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/hep.30882","volume":"71","author":"WZ Guo","year":"2020","unstructured":"Guo WZ, Fang HB, Cao SL, Chen SY, Li J, Shi JH, et al. Six-transmembrane epithelial antigen of the prostate 3 deficiency in hepatocytes protects the liver against ischemia-reperfusion injury by suppressing transforming growth factor-\u03b2-activated kinase 1. Hepatology. 2020;71:1037\u201354.","journal-title":"Hepatology."},{"key":"5277_CR30","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1172\/JCI37829","volume":"119","author":"C Brooks","year":"2009","unstructured":"Brooks C, Wei Q, Cho SG, Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Investig. 2009;119:1275\u201385.","journal-title":"J Clin Investig"},{"key":"5277_CR31","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.7150\/thno.30398","volume":"9","author":"X Yi","year":"2019","unstructured":"Yi X, Guo W, Shi Q, Yang Y, Zhang W, Chen X, et al. SIRT3-dependent mitochondrial dynamics remodeling contributes to oxidative stress-induced melanocyte degeneration in vitiligo. Theranostics. 2019;9:1614\u201333.","journal-title":"Theranostics."},{"key":"5277_CR32","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1111\/bph.14823","volume":"176","author":"J Geng","year":"2019","unstructured":"Geng J, Liu W, Gao J, Jiang C, Fan T, Sun Y, et al. Andrographolide alleviates Parkinsonism in MPTP-PD mice via targeting mitochondrial fission mediated by dynamin-related protein 1. Br J Pharmacol. 2019;176:4574\u201391.","journal-title":"Br J Pharmacol"},{"key":"5277_CR33","doi-asserted-by":"publisher","first-page":"101381","DOI":"10.1016\/j.redox.2019.101381","volume":"28","author":"T Yan","year":"2020","unstructured":"Yan T, Zhao Y. Acetaldehyde induces phosphorylation of dynamin-related protein 1 and mitochondrial dysfunction via elevating intracellular ROS and Ca(2+) levels. Redox Biol. 2020;28:101381.","journal-title":"Redox Biol"},{"key":"5277_CR34","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.1073\/pnas.0900653106","volume":"106","author":"M Brehme","year":"2009","unstructured":"Brehme M, Hantschel O, Colinge J, Kaupe I, Planyavsky M, K\u00f6cher T, et al. Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci USA. 2009;106:7414\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5277_CR35","doi-asserted-by":"publisher","first-page":"D529","DOI":"10.1093\/nar\/gky1079","volume":"47","author":"R Oughtred","year":"2019","unstructured":"Oughtred R, Stark C, Breitkreutz BJ, Rust J, Boucher L, Chang C, et al. The BioGRID interaction database: 2019 update. Nucleic Acids Res. 2019;47:D529\u2013d41.","journal-title":"Nucleic Acids Res"},{"key":"5277_CR36","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1074\/jbc.M510993200","volume":"281","author":"RN de Jong","year":"2006","unstructured":"de Jong RN, Ab E, Diercks T, Truffault V, Dani\u00ebls M, Kaptein R, et al. Solution structure of the human ubiquitin-specific protease 15 DUSP domain. The. J Biol Chem. 2006;281:5026\u201331.","journal-title":"J Biol Chem"},{"key":"5277_CR37","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/ncb2346","volume":"13","author":"M Inui","year":"2011","unstructured":"Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, Soligo S, et al. USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol. 2011;13:1368\u201375.","journal-title":"Nat Cell Biol"},{"key":"5277_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.2619","volume":"18","author":"PJ Eichhorn","year":"2012","unstructured":"Eichhorn PJ, Rod\u00f3n L, Gonz\u00e0lez-Junc\u00e0 A, Dirac A, Gili M, Mart\u00ednez-S\u00e1ez E, et al. USP15 stabilizes TGF-\u03b2 receptor I and promotes oncogenesis through the activation of TGF-\u03b2 signaling in glioblastoma. Nat Med. 2012;18:429\u201335.","journal-title":"Nat Med"},{"key":"5277_CR39","doi-asserted-by":"publisher","first-page":"101859","DOI":"10.1016\/j.redox.2021.101859","volume":"40","author":"S Li","year":"2021","unstructured":"Li S, Zhu Z, Xue M, Pan X, Tong G, Yi X, et al. The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice. Redox Biol. 2021;40:101859.","journal-title":"Redox Biol"},{"key":"5277_CR40","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/hep.28739","volume":"64","author":"S Yue","year":"2016","unstructured":"Yue S, Zhu J, Zhang M, Li C, Zhou X, Zhou M, et al. The myeloid heat shock transcription factor 1\/\u03b2-catenin axis regulates NLR family, pyrin domain-containing 3 inflammasome activation in mouse liver ischemia\/reperfusion injury. Hepatology. 2016;64:1683\u201398.","journal-title":"Hepatology."},{"key":"5277_CR41","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1089\/ars.2015.6492","volume":"24","author":"G Wang","year":"2016","unstructured":"Wang G, Yao J, Li Z, Zu G, Feng D, Shan W, et al. miR-34a-5p inhibition alleviates intestinal ischemia\/reperfusion-induced reactive oxygen species accumulation and apoptosis via activation of SIRT1 signaling. Antioxid Redox Signal. 2016;24:961\u201373.","journal-title":"Antioxid Redox Signal"},{"key":"5277_CR42","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/eurheartj\/ehu400","volume":"36","author":"A Akhmedov","year":"2015","unstructured":"Akhmedov A, Montecucco F, Braunersreuther V, Camici GG, Jakob P, Reiner MF, et al. Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways. Eur Heart J. 2015;36:516\u201326a.","journal-title":"Eur Heart J"},{"key":"5277_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/emboj\/16.4.706","volume":"16","author":"E Migliaccio","year":"1997","unstructured":"Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, Superti-Furga G, et al. Opposite effects of the p52shc\/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 1997;16:706\u201316.","journal-title":"EMBO J"},{"key":"5277_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pharmthera.2017.03.001","volume":"177","author":"M He","year":"2017","unstructured":"He M, Zhou Z, Wu G, Chen Q, Wan Y. Emerging role of DUBs in tumor metastasis and apoptosis: therapeutic implication. Pharmacol Therapeutics. 2017;177:96\u2013107.","journal-title":"Pharmacol Therapeutics"},{"key":"5277_CR45","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1038\/onc.2016.424","volume":"36","author":"WT Liu","year":"2017","unstructured":"Liu WT, Huang KY, Lu MC, Huang HL, Chen CY, Cheng YL, et al. TGF-\u03b2 upregulates the translation of USP15 via the PI3K\/AKT pathway to promote p53 stability. Oncogene. 2017;36:2715\u201323.","journal-title":"Oncogene."},{"key":"5277_CR46","doi-asserted-by":"publisher","first-page":"13813","DOI":"10.1111\/jcmm.15971","volume":"24","author":"B Yu","year":"2020","unstructured":"Yu B, Shen B, Ba Z, Liu Z, Yuan J, Zhao W, et al. USP15 promotes the apoptosis of degenerative nucleus pulposus cells by suppressing the PI3K\/AKT signalling pathway. J Cell Mol Med. 2020;24:13813\u201323.","journal-title":"J Cell Mol Med"},{"key":"5277_CR47","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bbrc.2009.08.015","volume":"388","author":"M Xu","year":"2009","unstructured":"Xu M, Takanashi M, Oikawa K, Tanaka M, Nishi H, Isaka K, et al. USP15 plays an essential role for caspase-3 activation during Paclitaxel-induced apoptosis. Biochem. Biophys. Res. Commun. 2009;388:366\u201371.","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"5277_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018;17:57\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"5277_CR49","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41375-021-01394-z","volume":"36","author":"M Niederkorn","year":"2022","unstructured":"Niederkorn M, Ishikawa C, H KM, Bartram J, Stepanchick E, B JR, et al. The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia. Leukemia 2022;36:438\u201351.","journal-title":"Leukemia"},{"key":"5277_CR50","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.str.2019.01.002","volume":"27","author":"J Teyra","year":"2019","unstructured":"Teyra J, Singer AU, Schmitges FW, Jaynes P, Kit Leng Lui S, Polyak MJ, et al. Structural and functional characterization of ubiquitin variant inhibitors of USP15. Struct (Lond, Engl: 1993). 2019;27:590\u2013605.e5.","journal-title":"Struct (Lond, Engl: 1993)"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05277-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05277-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05277-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T17:14:24Z","timestamp":1728062064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05277-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["5277"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05277-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"21 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"823"}}